1. Home
  2. SRRK vs PRVA Comparison

SRRK vs PRVA Comparison

Compare SRRK & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • PRVA
  • Stock Information
  • Founded
  • SRRK 2012
  • PRVA 2007
  • Country
  • SRRK United States
  • PRVA United States
  • Employees
  • SRRK N/A
  • PRVA 1140
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • PRVA Retail: Computer Software & Peripheral Equipment
  • Sector
  • SRRK Health Care
  • PRVA Technology
  • Exchange
  • SRRK Nasdaq
  • PRVA Nasdaq
  • Market Cap
  • SRRK 3.2B
  • PRVA 2.8B
  • IPO Year
  • SRRK 2018
  • PRVA 2021
  • Fundamental
  • Price
  • SRRK $34.04
  • PRVA $21.85
  • Analyst Decision
  • SRRK Strong Buy
  • PRVA Strong Buy
  • Analyst Count
  • SRRK 6
  • PRVA 14
  • Target Price
  • SRRK $42.17
  • PRVA $27.93
  • AVG Volume (30 Days)
  • SRRK 1.3M
  • PRVA 792.8K
  • Earning Date
  • SRRK 08-07-2025
  • PRVA 08-07-2025
  • Dividend Yield
  • SRRK N/A
  • PRVA N/A
  • EPS Growth
  • SRRK N/A
  • PRVA N/A
  • EPS
  • SRRK N/A
  • PRVA 0.12
  • Revenue
  • SRRK N/A
  • PRVA $1,801,244,000.00
  • Revenue This Year
  • SRRK N/A
  • PRVA $90.63
  • Revenue Next Year
  • SRRK $502.60
  • PRVA $10.51
  • P/E Ratio
  • SRRK N/A
  • PRVA $182.49
  • Revenue Growth
  • SRRK N/A
  • PRVA 6.79
  • 52 Week Low
  • SRRK $6.76
  • PRVA $16.37
  • 52 Week High
  • SRRK $46.98
  • PRVA $26.09
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 55.54
  • PRVA 34.75
  • Support Level
  • SRRK $30.97
  • PRVA $22.01
  • Resistance Level
  • SRRK $37.00
  • PRVA $23.28
  • Average True Range (ATR)
  • SRRK 2.05
  • PRVA 0.72
  • MACD
  • SRRK 0.23
  • PRVA -0.11
  • Stochastic Oscillator
  • SRRK 65.40
  • PRVA 11.46

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

About PRVA Privia Health Group Inc.

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Share on Social Networks: